Latest available resultsQuarter ended June 30, 202610-Q · July 30, 2026
Filed with the SECCigna Group
CIHealthcare
Next reportOctober 28, 2026pre-market · Analyst forecast 7.725 $/share
Revenue
$71.67B
▲ +6.7% vs prior year% YoY
Net income
$1.66B
▲ +8.4% vs prior year% YoY
EPS
6.29$
▲ +10.2% vs prior year% YoY
Net margin
2.3%
▲ +0.0 percentage points vs prior year pp YoY
Revenue▲ +6.7 %
Margins (% of revenue)GrossOperatingNet
Net income▲ +8.4 %
EPS▲ +10.2 %
View financial tableQuarter ended June 30, 2026
| Metric | Value | Context |
|---|---|---|
| Operations | ||
| Revenue | $71.67B | |
| Gross profit | $14.96B | 20.9 % |
| Operating income | $2.68B | 3.7 % |
| Net income | $1.66B | 2.3 % |
| R&D | — | never filed |
| EPS (diluted) | 6.29 $ | |
| Balance sheet | ||
| Assets | $157.08B | |
| Liabilities | $114.17B | |
| Equity | $42.91B | |
| Cash | $6.30B | |
| Capital | ||
| Shares outstanding | 264.24M | as of 2026-07-24 |
| Public float | — | |